永井 拓

Medicine & Life Sciences

1. Methamphetamine 100%
2. Schizophrenia 86%
3. Dopamine 71%
4. Nucleus Accumbens 71%
5. Memory 64%
6. Phencyclidine 63%
7. Tissue Plasminogen Activator 61%
8. Hippocampus 50%
9. Neurons 49%
10. Prefrontal Cortex 46%
11. Cognitive Dysfunction 44%
12. Fibrinolysin 42%
13. Psychology Recognition 37%
14. Morphine 35%
15. Reward 34%
16. Phosphorylation 34%
17. Amyloid 31%
18. Brain 29%
19. Dopamine D1 Receptors 29%
20. Acids 28%
21. Genes 27%
22. Astrocytes 27%
23. Clozapine 26%
24. Microinjections 25%
25. Animal Models 25%
26. Neurogenesis 24%
27. Nicotine 23%
28. PAR-1 Receptor 22%
29. Fear 22%
30. Proteins 21%
31. Dizocilpine Maleate 21%
32. Cognition 21%
33. Substance-Related Disorders 20%
34. Antipsychotic Agents 20%
35. Mitogen-Activated Protein Kinase 3 20%
36. Short-Term Memory 20%
37. Learning 19%
38. Mitogen-Activated Protein Kinase 1 19%
39. Spatial Memory 19%
40. Neuronal Plasticity 19%
41. N-Methyl-D-Aspartate Receptors 19%
42. Knockout Mice 18%
43. Dehydroepiandrosterone Sulfate 18%
44. Silybin 18%
45. Neurosteroids 17%
46. Haloperidol 17%
47. Prepulse Inhibition 17%
48. Corpus Striatum 15%
49. Sensory Gating 14%
50. Protein Domains 14%